Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01465516 · ClinicalTrials.gov registry record
Treating Hispanic Patients Diagnosed With Hepatitis C Using Boceprevir
A clinical trial, sponsored by Arrowhead Regional Medical Center.
- Terminated
- Registry status
- 105
- Enrollment target
NCT01465516 is a clinical trial that was terminated before completion, run by Arrowhead Regional Medical Center. The registered enrollment target is 105 participants.
The verdict
NCT01465516 was terminated before completion, sponsored by Arrowhead Regional Medical Center.
- TERMINATED
- Registry status
- 105 participants
- Enrollment target
Study Summary
Hypothesis Response guided therapy improves significantly the overall SVR in Hispanics compared to historical control. There is no difference in SVR between patients with an undetectable HCV RNA at week 8 and week 28 who received a 4 week lead-in of PR plus 24 weeks of PR+BOC based treatment and patients with detectable HCV RNA at week 8 and undetectable HCV RNA at week 24 who received a lead-in of PR plus 32 weeks PR+BOC followed by based therapy and 12 weeks of PR.
Interventions
- DRUG Boceprevir
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2011-11 |
| Est. Completion | 2013-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01465516
The ClinicalTrials.gov registry entry for NCT01465516 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 105 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Arrowhead Regional Medical Center, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Boceprevir is the first listed.
NCT01465516 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01465516 about?
NCT01465516 is a clinical study titled "Treating Hispanic Patients Diagnosed With Hepatitis C Using Boceprevir". Hypothesis Response guided therapy improves significantly the overall SVR in Hispanics compared to historical control. There is no difference in SVR between patients with an undetectable HCV RNA at week 8 and week 28 who received a 4 week lead-in of PR plus 24 weeks of PR+BOC based treatment and pat...
What is the current status of trial NCT01465516?
This trial is currently terminated. The enrollment target is 105 participants. The study started on 2011-11. Estimated completion is 2013-12.
What interventions are being tested in trial NCT01465516?
The interventions under investigation include: Boceprevir (DRUG).
Who is sponsoring clinical trial NCT01465516?
This trial is sponsored by Arrowhead Regional Medical Center, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.